Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information ...

A Maryland drug affordability board can move forward with a plan to cap how much the state and local governments pay for ...

SAVANNAH, Georgia — A new clinical education tool aims to speed the diagnosis of amyotrophic lateral sclerosis (ALS), which ...

Failed to import article template. Reason: Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app ...

The Philippine Press Institute (PPI) together with Novartis held a hybrid seminar-workshop for journalists entitled “Anatomy ...

The Fortune 500 Europe has a feeble share of tech companies. But its industrial giants are increasingly turning to generative ...

We think Biogen's neurology, immunology, and focus on rare diseases support a narrow moat. Biogen's strategy has its roots in the 2003 merger of Biogen (Avonex for treating multiple sclerosis, or MS) ...

DelveInsight's 'JAK Inhibitors Pipeline Insight 2024' report provides comprehensive global coverage of pipeline JAK ...

The company’s shares closed yesterday at $313.74. Welford covers the Healthcare sector, focusing on stocks such as Roche Holding AG, Sanofi, and Novartis. According to TipRanks, Welford has an average ...

Minnesota Gov. TIM WALZ will make a local stop in St. Paul in the morning, while his interview on Univision Radio’s “El Bueno ...

Molecular Partners (MOLN) and Orano Med announced the oral presentation of the latest preclinical data supporting MP0712 as a Radio-DARPin ...

The FDA issued a complete response letter (CRL) to Camurus, dealing a setback to the Swedish drugmaker’s efforts to bring its ...